Lumpectomy With Radiation or Mastectomy ?

For many women diagnosed with early breast cancer, the decision between lumpectomy with radiation and mastectomy is the most significant choice they will face in their entire treatment journey. It is also one of the most misunderstood. Many women assume that removing the whole breast is the safer option. Decades of clinical data say otherwise. Understanding what the evidence actually shows and what factors genuinely influence the right choice is what allows a woman to make an informed decision rather than an anxiety-driven one.

According to Dr. Garvit Chitkara, a trusted Breast Cancer Surgeon in Mumbai,
“One of the most common misconceptions I encounter is that mastectomy must be safer because it removes more. The data from multiple large trials over thirty years shows that survival is equivalent between lumpectomy with radiation and mastectomy for eligible early-stage patients. The decision should be based on tumour characteristics, patient anatomy, and personal preference not on the assumption that bigger surgery means better outcomes.”

What does the evidence say about survival outcomes?

The comparison between lumpectomy with radiation and mastectomy has been studied extensively since the 1980s, and the findings have been consistent across multiple landmark trials:

• Equivalent overall survival: Multiple randomised controlled trials, including the landmark NSABP B-06 trial and long-term follow-up data, confirm that overall survival rates are statistically equivalent between lumpectomy with radiation and mastectomy in eligible early-stage breast cancer patients. Choosing lumpectomy does not mean accepting a higher risk of dying from breast cancer.
• Local recurrence rates: Lumpectomy with radiation carries a slightly higher risk of local recurrence in the treated breast compared to mastectomy typically in the range of five to ten percent over ten years versus one to two percent after mastectomy. However, local recurrence after lumpectomy is salvageable with subsequent mastectomy and does not translate to worse survival.
• Mastectomy does not eliminate recurrence risk: Mastectomy significantly reduces local recurrence but does not eliminate it entirely. Chest wall recurrence can still occur, and the risk of distant metastasis is determined by tumour biology rather than the type of surgery performed.
• Radiation is a mandatory part of the lumpectomy approach: Lumpectomy without radiation has significantly higher local recurrence rates and is not considered standard of care except in carefully selected older low-risk patients. The comparison is always lumpectomy plus radiation versus mastectomy, not lumpectomy alone.

For patients where mastectomy is clinically indicated, understanding the surgical options available is the important next step. The modified radical mastectomy page covers what that procedure involves and when it is recommended.

Who is a candidate for lumpectomy and who needs mastectomy?

Eligibility for lumpectomy rather than mastectomy is determined by a combination of tumour and patient factors:

• Tumour size and location: Lumpectomy is typically feasible when the tumour is small relative to breast size and located in a position that allows complete excision with clear margins while preserving acceptable breast shape. Large tumours or those in central positions may require oncoplastic techniques or mastectomy depending on breast volume.
• Tumour focality: A single tumour site in one area of the breast is suitable for lumpectomy. Multiple tumours spread across different quadrants of the same breast are generally an indication for mastectomy, as achieving clear margins across multiple sites while preserving the breast is often not possible.
• Genetic risk and prophylactic intent: Women with BRCA1 or BRCA2 mutations face a significantly elevated lifetime risk of a second primary breast cancer. Many choose bilateral mastectomy for risk reduction rather than lumpectomy, even when lumpectomy would be technically feasible for their current tumour.
• Radiation eligibility: Lumpectomy requires post-operative radiation. Women who have previously received radiation to the chest, who are pregnant, or who have certain connective tissue disorders may not be suitable candidates for radiation and therefore cannot safely have lumpectomy as part of their treatment.

For women who choose or require mastectomy, the question of reconstruction becomes central to quality of life planning. The breast reconstruction blog covers the options and what the recovery involves.

Why Choose Dr Garvit Chitkara ?

Dr. Garvit Chitkara is Associate Director of Breast Surgical Oncology and Oncoplasty at Nanavati Max Institute of Cancer Care, Mumbai, with over 17 years of experience in breast surgical oncology. He has published research on breast conservation surgery decision-making in Indian cohorts and brings both the clinical evidence and the technical capability to offer all surgical options lumpectomy, oncoplastic conservation, and the full range of mastectomy procedures under one specialist. Patients receive a clear, evidence-based explanation of what each option offers, what it involves, and what recovery looks like, so the decision is made with full information. 

FAQ

Disclaimer: This blog is for informational purposes only and does not replace personalised medical advice from a qualified healthcare professional.